https://doi.org/10.4081/itjm.2024.1703

The use of Beck Depression Inventory for assessment of depressive symptoms in epilepsy: a single-center experience in Kosovo

Vol. 18 No. 1 (2024)
Published: 14 February 2024
Beck Depression Inventory, BDI, depression, epilepsy, risk assessment
Abstract Views: 1306
PDF: 415
HTML: 200
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Valbona Govori
https://orcid.org/0009-0001-0858-8027
Neurology Clinic, University Clinical Centre of Kosovo, Prishtina; Faculty of Medicine, University of Prishtina “Hasan Prishtina”, Prishtina, Kosovo.
Esra Zhubi
https://orcid.org/0009-0000-2715-995X
Neurology Clinic, University Clinical Centre of Kosovo, Prishtina; Faculty of Medicine, University of Prishtina “Hasan Prishtina”, Prishtina, Kosovo.
Pranvera Bytyci
https://orcid.org/0009-0001-7953-9054
Neurology Clinic, University Clinical Centre of Kosovo, Prishtina, Kosovo.
Edita Malazogu
Neurology Clinic, University Clinical Centre of Kosovo, Prishtina, Kosovo.
Rina Hoxha
rina.hoxha@uni-pr.edu
https://orcid.org/0009-0004-8574-2069
Faculty of Medicine, University of Prishtina “Hasan Prishtina”, Prishtina; National Institute of Public Health of Kosovo, Prishtina, Kosovo.

Depressive disorders are common comorbidities in people living with epilepsy, and they can have a profound effect on both the course of epilepsy and the overall quality of life of those affected. A total of 125 patients diagnosed with epilepsy were recruited from the outpatient care in the Neurology Clinic at the University Clinical Centre of Kosovo, over a 3-month period (October 2023 to December 2023). The Beck Depression Inventory was used to measure the severity of depressive symptoms in these participants. In this study, we observed that 75% of women and 61.4% of men reported mild, moderate, or severe depressive symptoms. According to the severity of depressive symptoms, participants with generalized epilepsy were more likely to report severe depressive symptoms. They represented 59.0% of the participants reporting mild depressive symptoms, 61.5% of the participants reporting moderate depressive symptoms, and 47.6% of the participants reporting severe depression. Assessing and addressing depressive symptoms in individuals with epilepsy through a multidimensional approach and standardized methods is a critical aspect of providing quality care for all patients.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

PlumX Metrics

PlumX Metrics  provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Alhashimi R, Thoota S, Ashok T, et al. Comorbidity of Epilepsy and Depression: Associated Pathophysiology and Management. Cureus 2022;14:e21527. DOI: https://doi.org/10.7759/cureus.21527
Panayiotopoulos CP. The new ILAE report on terminology and concepts for the organization of epilepsies: critical review and contribution. Epilepsia 2012;53:399-404. DOI: https://doi.org/10.1111/j.1528-1167.2011.03381.x
Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology 2017;88:296-303. DOI: https://doi.org/10.1212/WNL.0000000000003509
Mula M, Brodie MJ, de Toffol B, et al. ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy. Epilepsia 2022;63:316-34. DOI: https://doi.org/10.1111/epi.17140
Wang G, Si TM, Li L, et al. Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China. Neuropsychiatr Dis Treat 2019;15:1723-36. DOI: https://doi.org/10.2147/NDT.S195505
Langer JK, Tonge NA, Piccirillo M, et al. Symptoms of social anxiety disorder and major depressive disorder: A network perspective. J Affect Disord 2019;243:531-8. DOI: https://doi.org/10.1016/j.jad.2018.09.078
Pettorruso M, d’Andrea G, Martinotti G, et al. Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates. Brain Sci 2020;10:519. DOI: https://doi.org/10.3390/brainsci10080519
Mula M. Developments in depression in epilepsy: screening, diagnosis, and treatment. Expert Rev Neurother 2019;19:269-76. DOI: https://doi.org/10.1080/14737175.2019.1585244
Elger CE, Johnston SA, Hoppe C. Diagnosing and treating depression in epilepsy. Seizure 2017;44:184-93.
Pacchiarotti I, Kotzalidis GD, Murru A, et al. Mixed Features in Depression: The Unmet Needs of Diagnostic and Statistical Manual of Mental Disorders Fifth Edition. Psychiatr Clin North Am 2020;43:59-68. DOI: https://doi.org/10.1016/j.psc.2019.10.006
Smarr KL, Keefer AL. Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res (Hoboken) 2011;63:S454-S466. DOI: https://doi.org/10.1002/acr.20556
Sehlo MG, Mohamed WS, Youssef UM, et al. Prevalence and determinants of depression in patients with epilepsy during the COVID-19 pandemic. Middle East Curr Psychiatr 2022;29:22. DOI: https://doi.org/10.1186/s43045-022-00190-4
Elger CE, Johnston SA, Hoppe C. Diagnosing and treating depression in epilepsy. Seizure 2017;44:184-93. DOI: https://doi.org/10.1016/j.seizure.2016.10.018
Engidaw NA, Bacha L, Kenea A. Prevalence of depression and associated factors among epileptic patients at Ilu Ababore zone hospitals, South West Ethiopia, 2017: a cross-sectional study. Ann Gen Psychiatr 2020;19:19. DOI: https://doi.org/10.1186/s12991-020-00268-5
Tan JK, Khoo CS, Beh HC, et al. Prevalence and associated risk factors of undiagnosed depression among people with epilepsy in a multiethnic society. Epilepsy Res 2021;178:106772. DOI: https://doi.org/10.1016/j.eplepsyres.2021.106772
Zhong R, Chen Q, Li M, et al. Factors contributing to comorbid depressive symptoms in adult people with newly diagnosed epilepsy: A 12-month longitudinal study. Epilepsy Behav 2021;124:108326. DOI: https://doi.org/10.1016/j.yebeh.2021.108326
Vacca M, Fernandes M, Spanetta M, et al. Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center. Neurol Sci 2022;43:1965-74. DOI: https://doi.org/10.1007/s10072-021-05589-1
Kanner AM. Depression in Epilepsy Is Much More Than a Reactive Process. Epilepsy Curr 2003;3:202-3. DOI: https://doi.org/10.1046/j.1535-7597.2003.03609.x
Gill SJ, Lukmanji S, Fiest KM, et al. Depression screening tools in persons with epilepsy: A systematic review of validated tools. Epilepsia 2017;58:695-705. DOI: https://doi.org/10.1111/epi.13651
Lee SA, Im K, Jung M, Seo JY. Korean QoL in Epilepsy Study Group. General self-efficacy differentially moderates depressive symptoms in adults with epilepsy depending on seizure severity. Epilepsy Behav 2023;138:108990. DOI: https://doi.org/10.1016/j.yebeh.2022.108990
Wang YP, Gorenstein C. Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression Inventory-II. Clinics (Sao Paulo) 2013;68:1274-87. DOI: https://doi.org/10.6061/clinics/2013(09)15
Rathore JS, Jehi LE, Fan Y, et al. Validation of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adults with epilepsy. Epilepsy Behav 2014;37:215-20. DOI: https://doi.org/10.1016/j.yebeh.2014.06.030
Wagner JL, Kellermann T, Mueller M, et al. Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy [published correction appears in Epilepsia. 2018 Oct;59(10):2004]. Epilepsia 2016;57:1265-70. DOI: https://doi.org/10.1111/epi.13446
Biracyaza E, Habimana S, Rusengamihigo D. Psychometric Properties of the Beck Depression Inventory (BDI-II) in Cancer Patients: Cancer Patients from Butaro Ambulatory Cancer Center, Rwanda. Psychol Res Behav Manag 2021;14:665-74. DOI: https://doi.org/10.2147/PRBM.S306530
Seppänen M, Lankila T, Auvinen J, et al. Cross-cultural comparison of depressive symptoms on the Beck Depression Inventory-II, across six population samples. BJPsych Open 2022;8:e46. DOI: https://doi.org/10.1192/bjo.2022.13
Wang X, Wang Y, Xin T. The Psychometric Properties of the Chinese Version of the Beck Depression Inventory-II With Middle School Teachers. Front Psychol 2020;11:548965. DOI: https://doi.org/10.3389/fpsyg.2020.548965
do Nascimento RLF, Fajardo-Bullon F, Santos E, et al. Psychometric Properties and Cross-Cultural Invariance of the Beck Depression Inventory-II and Beck Anxiety Inventory among a Representative Sample of Spanish, Portuguese, and Brazilian Undergraduate Students. Int J Environ Res Public Health 2023;20:6009. DOI: https://doi.org/10.3390/ijerph20116009
de Oliveira GN, Lessa JM, Gonçalves AP, et al. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI). Epilepsy Behav 2014;34:50-4. DOI: https://doi.org/10.1016/j.yebeh.2014.03.003

How to Cite

Govori, V., Zhubi, E., Bytyci, P., Malazogu, E., & Hoxha, R. (2024). The use of Beck Depression Inventory for assessment of depressive symptoms in epilepsy: a single-center experience in Kosovo. Italian Journal of Medicine, 18(1). https://doi.org/10.4081/itjm.2024.1703
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.